Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Risperdal Consta vs Oral Antipsychotics in Bipolar Disorder
NCT00246246Phase 3Completed
- Sponsor
- Janssen Ortho
- Start
- Jan 2004
- Modality
- Small Molecules
01
Overview
A Phase 3 trial of risperidone in bipolar disorder (BD), sponsored by Janssen Ortho. Started Jan 2004; status: completed.
02
Drugs
risperidone
03
Conditions
bipolar disorder (BD)
Beyond the preview
Go deeper on NCT00246246.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00246246.